Cardiac Involvement in Wilson's Disease

计划入组 150 人 · 首次发布于 2022 年 8 月 9 日

Oral Health and Wilson's Disease: SOMAWI

计划入组 150 人 · 首次发布于 2022 年 7 月 5 日

International Wilson's Disease Patient Registry (iWilson Registry)

计划入组 500 人 · 首次发布于 2022 年 2 月 15 日

Wilson's Disease (Prime Medicine)

Penicillamine(Cuprimine, Depen)

C₅H₁₁NO₂S · Rx

Triethylenetetramine(Cuvrior, Syprine, Cuprior, Cufence)

C₆H₁₈N₄ · Rx

Rare Disease Research, LLC

CASTLEMAN DISEASE COLLABORATIVE NETWORK

United States

CURE RARE DISEASE, INC.

United States

Telomir Pharmaceuticals' Telomir-1 Shows Copper-Binding Potential for Wilson's Disease Treatment

Prime Medicine Advances Gene Editing Pipeline with Key Programs for CGD, Wilson's Disease, and AATD

Orphalan Makes History as First European Company to Enter China's Wilson Disease Market with "Ke Pei Ou"